title: Altered circadian rhythms of natural killer (NK) cell activity in patients with autoimmune rheumatic diseases.
abstract: Natural Killer (NK) cells are a lymphocyte subset actively involved in cytotoxicity against tumor-transformed and virus-infected cells; they are a reliable model for the study of neuroendocrine-immune interactions. In previous works we demonstrated that in healthy subjects NK activity of peripheral blood mononuclear cells (PBMC) and susceptibility to endogenous modifiers display statistically validated circadian rhythms. In rheumatoid arthritis (RA) and in other autoimmune rheumatic diseases abnormalities of the circadian rhythm of serum cortisol and altered levels of NK cell activity have been reported. We evaluated the circadian pattern of NK cell activity in 7 hospitalized patients with autoimmune rheumatic diseases (4 RA, 1 scleroderma, 2 mixed connective tissue disease). Temporal variations of in vitro responses to either positive recombinant (immune interferon, r IFN-gamma IFN-gamma: 650 IU/ml; recombinant interleukin-2, r IL-2 IL-2: 100 IU/ml) or negative (cortisol: 10(-6) M) modifiers were also studied. Blood was drawn at 4h intervals for 24 h, starting at 0800. PBMC preparations were immediately separated and incubated for 20h in the presence or absence of modifiers. NK activity was assessed with a direct non-radiometric 4h cytolytic assay, using K 562 cells as targets. Significant circadian variations of spontaneous NK activity were documented only in women with RA, with a peak in the evening hours and a minimum in the night or in the early morning (p < 0.05, PR 51.5%, phi 1829). Population-mean cosinor analysis did not yield detection of significant circadian variations of in vitro responsiveness to modifiers.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Dipartimento di Scienze Cliniche e Biologiche, Università degli Studi di Torino, Ospedale S. Luigi Gonzaga, Orbassano, Italy.
authors.forename: R G
authors.initials: RG
authors.lastname: Masera
authors.forename: R
authors.initials: R
authors.lastname: Carignola
authors.forename: A H
authors.initials: AH
authors.lastname: Staurenghi
authors.forename: M L
authors.initials: ML
authors.lastname: Sartori
authors.forename: A
authors.initials: A
authors.lastname: Lazzero
authors.forename: G
authors.initials: G
authors.lastname: Griot
authors.forename: A
authors.initials: A
authors.lastname: Angeli
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology*; D002940:Circadian Rhythm / Q000276:immunology*; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D015213:Neuroimmunomodulation; D012216:Rheumatic Diseases / Q000276:immunology*